Increasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests

Abstract

ICA512 autoantibody titers associate with progressive abnormalities in glucose metabolism in subjects at risk for type 1 diabetes. Fluctuations in autoantibody titers do not correlate with lower rates of progression to clinical disease.